Severe CNS side-effect and persistent high efavirenz plasma levels in a patient with HIV/HCV coinfection and liver cirrhosis

Markus Bickel From the HIV Treatment and Research Unit, JW Goethe University, FrankfurtCorrespondence[email protected]

Christoph Stephan From the HIV Treatment and Research Unit, JW Goethe University, Frankfurt

Carsten Rottmann From the HIV Treatment and Research Unit, JW Goethe University, Frankfurt

Amina Carlebach From the HIV Treatment and Research Unit, JW Goethe University, Frankfurt

Anette Haberl From the HIV Treatment and Research Unit, JW Goethe University, Frankfurt

Michael Kurowski HIV Laboratory, Auguste Viktoria Hospital, Berlin, Germany

Schlomo Staszewski From the HIV Treatment and Research Unit, JW Goethe University, Frankfurt

show all

References

Marzolini C, Telenti A, Decosterd LA, Greub G, Biollaz J, Buclin T. Efavirenz plasma levels can predict treatment failure and central nervous system side-effects in HIV-1 infected patients. AIDS 2001; 15: 1193–4
Web of Science ®Google Scholar
Maserati R, Villani P, Seminari E, Pan A, Lo Caputo S, Regazzi MB. High plasma levels of nelfinavir and efavirenz in 2 HIV-positive patients with hepatic disease. AIDS 1999; 13: 870–1
PubMed Web of Science ®Google Scholar
Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431–5
PubMed Web of Science ®Google Scholar
Veldkamp AI, van Heeswijk RP, Meenhorst PL, Mulder JW, Lange JM, Beijnen JH, Hoetelmans RM. Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl 1999; 734: 55–61
PubMed Web of Science ®Google Scholar
Summary of product characteristics (SmPC), Hoffmann-La Roche; January 2004.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Severe CNS side-effect and persistent high efavirenz plasma levels in a patient with HIV/HCV coinfection and liver cirrhosis

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Severe CNS side-effect and persistent high efavirenz plasma levels in a patient with HIV/HCV coinfection and liver cirrhosis

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date